Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
Not yet recruiting
- Conditions
- Chronic Lymphocytic Leukemia
- Registration Number
- NCT05899543
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
This research study aims to address the limited understanding of the challenges faced by specific demographic groups of chronic lymphocytic leukemia patients in their participation in clinical trials.
This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic leukemia as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chronic lymphocytic leukemia patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient has been diagnosed with chronic lymphocytic leukemia
- Patient is a minimum of 18 years or older
- Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion Criteria
- Pregnant or lactating women
- Patients who are currently receiving any other investigational drug
- Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of chronic lymphocytic leukemia patients who decide to join in a clinical study 3 months Rate of patients who remain in an chronic lymphocytic leukemia clinical study to completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States